Aiosyn

Nijmegen, Netherlands Founded: 2021 • Age: 5 yrs
AI-based tools are developed for clinical disease diagnosis by providers.

About Aiosyn

Aiosyn is a Healthcare company based in Nijmegen (Netherlands) founded in 2021 by Jeroen Van der Laak, Patrick De Boer, and Wouter Bulten. It operates as an AI-based tools are developed for clinical disease diagnosis by providers. Aiosyn has raised $4.94 million across 3 funding rounds from investors including TNO, Oost NL and Health Innovations. Its chief executive is Patrick De Boer. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include PaxeraHealth, Bio-AI Health, Visla Labs, Carenostics and lifespin and 1 more; 4 of its 6 listed competitors have raised funding.

Company details

Aiosyn was founded in 2021 in Nijmegen, Netherlands, within the health technology sector. Software has been created to support providers in clinical disease diagnosis, with specific features for breast and prostate cancer diagnostics, as well as computational pathology. Operations focus on AI-driven assistance for pathology workflows, targeting medical professionals in diagnostic processes across relevant geographies.

  • Headquarters Nijmegen, Netherlands
  • Founders Jeroen Van der Laak, Patrick De Boer, Wouter Bulten
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website aiosyn.com
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $4.94M (USD)

    in 3 rounds

  • Latest Funding Round
    $2.82M (USD), Series A

    Sep 2025

  • Investors
    TNO

    & 3 more

Funding Insights of Aiosyn

Aiosyn has successfully raised a total of $4.94M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.82 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.94M
  • Total Rounds 3
  • Last Round Series A β€” $2.82M
  • Investors Count 4

All 3 funding rounds of Aiosyn with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2025$2.82MSeries A––
Dec 2022$2.12MSeed–Health Innovations
Feb 2022–Seed–LUMO Labs
Valuation history

4 investors in total: 4 institutional.

Investors in Aiosyn

Aiosyn has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include TNO, Oost NL and Health Innovations.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Health Innovations is focused on investing in healthcare improvements.
2007healthinnovations.nlNetherlands
Sector-agnostic VC firm investing in geographies such as the Netherlands
2003oostnl.nlApeldoorn, Netherlands
Opportunities are created for impact-driven ventures in emerging technologies.
–lumolabs.ioEindhoven, Netherlands
Management research, transportation, and healthcare consulting services are provided.
1932tno.nlAmsterdam, Netherlands
Premium access

Investor details for Aiosyn

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Aiosyn

5 people are tracked at Aiosyn (4 in leadership, 1 in team).

NameRoleGroup
Jeroen Van der Laak
Co-FounderLeadership
Patrick De Boer
Co-Founder & CEOLeadership
Wouter Bulten
Co-FounderLeadership
David Tellez
Chief Technology OfficerLeadership
Thomas de Bel
AI ScientistTeam
Premium access

Complete people profiles for Aiosyn

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Aiosyn

3 dated milestones of Aiosyn across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aiosyn is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $2.8M.

Competitors of Aiosyn

Aiosyn has 6 listed competitors in our database, 4 of them funded. They include PaxeraHealth, Bio-AI Health, Visla Labs, Carenostics and lifespin, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
paxerahealth.com2009Boston, United States$5.5M–
AI-based medical image management solutions are offered for organizations.
bioaihealth.com2020Goffstown, United States$3.5M–
AI-based disease diagnosis is provided for healthcare professionals.
visla.ai2018San Francisco, United States––
Functions as an AI-based tool for disease diagnosis in healthcare.
carenostics.com2021United States$5M–
AI-based tools are employed for disease diagnosis.
lifespin.health2017Regensburg, Germany$634,318–
Cloud and AI-based diagnostics are provided for health providers.
healium.ai2019Singapore––
AI-based solutions for early kidney disease detection are offered.
Premium access

Detailed competitors of Aiosyn

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as Aiosyn (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aiosyn

Premium access

Complete news archive for Aiosyn

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aiosyn

Aiosyn was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Aiosyn is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.

Patrick De Boer is the current CEO of Aiosyn. They have also founded this company.

Aiosyn is a funded company, having raised a total of $4.94M across 3 funding rounds to date.

Aiosyn was founded in 2021 in Nijmegen, Netherlands, within the health technology sector. Software has been created to support providers in clinical disease diagnosis, with specific features for breast and prostate cancer diagnostics, as well as computational pathology. Operations focus on AI-driven assistance for pathology workflows, targeting medical professionals in diagnostic processes across relevant geographies.

Aiosyn's top competitors include Bio-AI Health, lifespin and PaxeraHealth.

Aiosyn has 4 investors. Key investors include TNO, Oost NL, Health Innovations, and LUMO Labs.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available